Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yiqian Wan is active.

Publication


Featured researches published by Yiqian Wan.


Journal of Medicinal Chemistry | 2012

From the First Selective Non-Peptide AT(2) Receptor Agonist to Structurally Related Antagonists

Murugaiah M. S. Andappan; Xiongyu Wu; Charlotta Wallinder; A. K. Mahalingam; Yiqian Wan; Christian Sköld; Milad Botros; Marie-Odile Guimond; Advait A. Joshi; Fred Nyberg; Nicole Gallo-Payet; Anders Hallberg; Mathias Alterman

A para substitution pattern of the phenyl ring is a characteristic feature of the first reported selective AT(2) receptor agonist M024/C21 (1) and all the nonpeptidic AT(2) receptor agonists described so far. Two series of compounds structurally related to 1 but with a meta substitution pattern have now been synthesized and biologically evaluated for their affinity to the AT(1) and AT(2) receptors. A high AT(2)/AT(1) receptor selectivity was obtained with all 41 compounds synthesized, and the majority exhibited K(i) ranging from 2 to 100 nM. Five compounds were evaluated for their functional activity at the AT(2) receptor, applying a neurite outgrowth assay in NG108-15 cells. Notably, four of the five compounds, with representatives from both series, acted as potent AT(2) receptor antagonists. These compounds were found to be considerably more effective than PD 123,319, the standard AT(2) receptor antagonist used in most laboratories. No AT(2) receptor antagonists were previously reported among the derivatives with a para substitution pattern. Hence, by a minor modification of the agonist 1 it could be transformed into the antagonist, compound 38. These compounds should serve as valuable tools in the assessment of the role of the AT(2) receptor in more complex physiological models.


Tetrahedron Letters | 2003

Boron trichloride as an efficient and selective agent for deprotection of tert-butyl aryl sulfonamides

Yiqian Wan; Xiongyu Wu; Mahalingam A. Kannan; Mathias Alterman

Boron trichloride as an efficient and selective agent for deprotection of tert-butyl aryl sulfonamides


Bioorganic & Medicinal Chemistry | 2010

Selective angiotensin II AT(2) receptor agonists with reduced CYP 450 inhibition.

A. K. Mahalingam; Yiqian Wan; A. M. S. Murugaiah; Charlotta Wallinder; Xiongyu Wu; Bianca Plouffe; Milad Botros; Fred Nyberg; Anders Hallberg; Nicole Gallo-Payet; Mathias Alterman

Structural alterations to the benzylic position of the first drug-like selective angiotensin II AT(2) receptor agonist (1) have been performed, with the emphasis to reduce the CYP 450 inhibitory property of the initial structure. The imidazole moiety, responsible for the CYP 450 inhibitory effect in 1, was replaced with various heterocycles. In addition, the modes of attachment of the heterocycles, that is, carbon versus nitrogen attachment, and introduction of carbonyl functionalities to the benzylic position have been evaluated. In all the three series, AT(2) receptor ligands with affinity in the lower nanomolar range were identified. None of the analogues, regardless of the substituents, exhibited any affinity for the AT(1) receptor. Compounds with substantially reduced inhibition of the CYP 450 enzymes were obtained. Among them the compound 60 was found to induce neurite elongation in NG 108-15 cells and served as potent AT(2) selective agonist.


Synthetic Communications | 2005

Scandium Triflate as an Efficient and Recyclable Catalyst for the Deprotection of Tert‐Butyl Aryl Sulfonamides

A. K. Mahalingam; Xiongyu Wu; Yiqian Wan; Mathias Alterman

Abstract A mild and efficient method for deprotection of tert‐butyl sulfonamide groups utilizing Sc(OTf)3 as deprotecting reagent has been developed. A variety of tert‐butyl aryl sulfonamides used under these conditions gave the corresponding primary sulfonamides in high yields. The Lewis acid catalyst could be fully recovered and reused with maintained activity after the reactions.


Journal of Medicinal Chemistry | 2004

Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT2 Receptor Agonist

Yiqian Wan; Charlotta Wallinder; Bianca Plouffe; Hélène Beaudry; A. K. Mahalingam; Xiongyu Wu; Berndt Johansson; Mathias Holm; Milad Botoros; Anders Karlén; Anders Pettersson; Fred Nyberg; Lars Fändriks; Nicole Gallo-Payet; Anders Hallberg; Mathias Alterman


Journal of Organic Chemistry | 2002

Dimethylformamide as a carbon monoxide source in fast palladium-catalyzed aminocarbonylations of aryl bromides

Yiqian Wan; Mathias Alterman; Mats Larhed; Anders Hallberg


ACS Combinatorial Science | 2003

Formamide as a combined ammonia synthon and carbon monoxide source in fast palladium-catalyzed aminocarbonylations of aryl halides

Yiqian Wan; Mathias Alterman; Mats Larhed; Anders Hallberg


Tetrahedron Letters | 2004

Fast microwave promoted palladium-catalyzed synthesis of phthalides from bromobenzyl alcohols utilizing DMF and Mo(CO)6 as carbon monoxide sources

Xiongyu Wu; A. K. Mahalingam; Yiqian Wan; Mathias Alterman


Journal of Medicinal Chemistry | 2004

First Reported Nonpeptide AT1 Receptor Agonist (L-162,313) Acts as an AT2 Receptor Agonist in Vivo

Yiqian Wan; Charlotta Wallinder; Berndt Johansson; Mathias Holm; A. K. Mahalingam; Xiongyu Wu; Milad Botros; Anders Karlén; Anders Pettersson; Fred Nyberg; Lars Fändriks; and Anders Hallberg; Mathias Alterman


Journal of Medicinal Chemistry | 2006

Selective Angiotensin II AT2 Receptor Agonists: Arylbenzylimidazole Structure−Activity Relationships

Xiongyu Wu; Yiqian Wan; A. K. Mahalingam; A. M. S. Murugaiah; Bianca Plouffe; Milad Botros; Anders Karlén; Mathias Hallberg; Nicole Gallo-Payet; Mathias Alterman

Collaboration


Dive into the Yiqian Wan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bianca Plouffe

Université de Sherbrooke

View shared research outputs
Researchain Logo
Decentralizing Knowledge